Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -29.25%4.44B | 16.51%32.51B | -31.26%9.88B | 295.23%10.85B | -21.97%5.52B | 68.64%6.27B | -19.01%27.91B | 90.35%14.38B | -47.67%2.74B | -31.27%7.07B |
Net profit before non-cash adjustment | 32.59%7.42B | 114.61%27.88B | 171.64%11.15B | 6.42%5.19B | 208.02%5.95B | 169.15%5.59B | -24.57%12.99B | 416.23%4.1B | 19.32%4.88B | -64.63%1.93B |
Total adjustment of non-cash items | -39.59%3.13B | -27.29%9.45B | -437.97%-6.19B | 9.92%5.93B | -12.25%4.53B | 44.41%5.18B | -30.62%12.99B | -156.84%-1.15B | -25.23%5.39B | 47.31%5.17B |
-Depreciation and amortization | 1.86%4.39B | 2.33%17.7B | 2.49%4.45B | 2.49%4.49B | 3.36%4.46B | 0.96%4.31B | 1.42%17.3B | 5.32%4.34B | -0.43%4.38B | 1.48%4.32B |
-Reversal of impairment losses recognized in profit and loss | 294.74%75M | 34.00%2.02B | 25.70%1.79B | 135.00%47M | 1,184.62%167M | -64.15%19M | 330.29%1.51B | 1,214.81%1.42B | -72.22%20M | -83.12%13M |
-Share of associates | -79.01%-145M | -3.40%-578M | 93.69%-98M | -27.74%-198M | -115.12%-201M | 55.00%-81M | 44.93%-559M | -1,286.61%-1.55B | 39.69%-155M | 559.86%1.33B |
-Disposal profit | -557.03%-1.14B | -24,712.20%-10.09B | -1,463.47%-10.91B | 104.22%339M | -14.91%234M | -16.44%249M | -97.83%41M | -250.11%-698M | -75.11%166M | -43.53%275M |
-Other non-cash items | -107.76%-53M | 107.46%395M | 69.69%-1.41B | 27.34%1.25B | 83.20%-129M | 180.07%683M | -1,279.29%-5.3B | -82.31%-4.66B | -57.82%984M | 24.85%-768M |
Changes in working capital | -35.60%-6.11B | -351.04%-4.82B | -56.88%4.93B | 96.37%-273M | -16,460.00%-4.97B | -131.26%-4.51B | 228.17%1.92B | 141.24%11.43B | -24.31%-7.53B | -102.28%-30M |
-Change in receivables | -125.40%-2.7B | 0.98%-7.3B | -61.17%4.31B | 117.79%1.96B | -144.03%-12.38B | 49.49%-1.2B | -378.88%-7.37B | -5.22%11.11B | -59.13%-11.04B | -95.75%-5.07B |
-Change in inventory | -67.39%-3.93B | -123.74%-1.09B | -174.27%-1.57B | -15.49%2.21B | -51.45%618M | -64.40%-2.35B | 319.76%4.57B | 185.08%2.11B | 636.62%2.62B | -28.88%1.27B |
-Change in payables | 181.76%3.35B | -47.18%2.87B | 80.59%-698M | -168.95%-2.19B | 191.70%4.57B | -72.23%1.19B | 583.11%5.44B | 40.55%-3.6B | 12.53%3.18B | 937.97%1.57B |
-Provision for loans, leases and other losses | -43.27%-2.77B | 938.10%1.09B | 46.43%2.94B | -5.83%-2.2B | -5.31%2.28B | 13.56%-1.93B | 157.07%105M | 16.03%2.01B | 1.66%-2.08B | -3.29%2.41B |
-Changes in other current assets | 68.64%-69M | 51.40%-400M | 71.22%-59M | 72.12%-58M | 69.86%-63M | -9.45%-220M | -9.59%-823M | -10.22%-205M | -10.64%-208M | -8.85%-209M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 6.25%-90M | -6.65%-369M | 9.89%-82M | -17.44%-101M | -12.50%-90M | -7.87%-96M | 11.51%-346M | -19.74%-91M | 21.82%-86M | 14.89%-80M |
Interest received (cash flow from operating activities) | -20.83%418M | 17.11%1.37B | 27.32%233M | 21.93%506M | 10.87%102M | 10.23%528M | 3.91%1.17B | -45.54%183M | 33.44%415M | 1.10%92M |
Tax refund paid | -431.15%-7.86B | 27.86%-3.05B | 20.00%-100M | 25.52%-1.56B | 221.52%96M | 22.96%-1.48B | 26.75%-4.23B | -390.70%-125M | 16.73%-2.1B | 37.30%-79M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 2.3B | 230,300.00%2.3B | -1M | 200.00%1M |
Operating cash flow | -159.31%-3.1B | 13.65%30.47B | -40.33%9.93B | 896.50%9.69B | -19.69%5.62B | 138.88%5.22B | -8.88%26.81B | 111.89%16.65B | -66.75%972M | -31.04%7B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 8.78%-4.08B | 5.85%-18.54B | 52.18%-3.12B | -94.35%-6.53B | 13.36%-4.41B | 5.07%-4.48B | 1.31%-19.69B | -49.69%-6.53B | 24.69%-3.36B | 13.24%-5.09B |
Net investment product transactions | 1,275.00%47M | 14,653.01%12.08B | 63,321.05%12.05B | -83.04%196M | 78.72%-163M | 99.19%-4M | 79.04%-83M | 2,000.00%19M | 397.94%1.16B | -25,433.33%-766M |
Advance cash and loans provided to other parties | 25.00%-3M | -942.86%-73M | -466.67%-17M | -2,250.00%-47M | -400.00%-5M | -300.00%-4M | -133.33%-7M | -200.00%-3M | ---2M | ---1M |
Repayment of advance payments to other parties and cash income from loans | 100.00%14M | 700.00%72M | 175.00%11M | 2,300.00%48M | 200.00%6M | 600.00%7M | -87.50%9M | -84.62%4M | -83.33%2M | -83.33%2M |
Net changes in other investments | -28.57%35M | 3.33%155M | -61.19%26M | 39.39%46M | 78.95%34M | 58.06%49M | 100.00%150M | 415.38%67M | 153.23%33M | 480.00%19M |
Investing cash flow | 9.89%-3.99B | 67.86%-6.31B | 239.02%8.95B | -189.51%-6.29B | 22.24%-4.54B | 14.45%-4.43B | 2.88%-19.62B | -48.96%-6.44B | 55.67%-2.17B | 0.49%-5.84B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 85.88%-48M | -347.83%-10.75B | -21.85%-5.14B | -105.49%-106M | -2,336.79%-5.17B | -454.17%-340M | 64.34%-2.4B | -153.26%-4.22B | 113.15%1.93B | -90.99%-212M |
Net common stock issuance | 0.00%-1M | -100.00%-6M | 0.00%-1M | -100.00%-2M | -100.00%-2M | ---1M | 40.00%-3M | 0.00%-1M | 0.00%-1M | 50.00%-1M |
Cash dividends paid | -33.79%-5.32B | 0.00%-4.06B | 0.00%-1M | -50.00%-3M | 0.00%-78M | 0.03%-3.97B | -49.94%-4.06B | 0.00%-1M | -100.00%-2M | -73.33%-78M |
Cash dividends for minorities | 0.00%-2M | 0.00%-2M | --0 | --0 | --0 | 0.00%-2M | 0.00%-2M | --0 | --0 | --0 |
Net other fund-raising expenses | -80.66%-327M | -0.97%-833M | 70.26%-218M | -168.40%-223M | 6.64%-211M | 5.73%-181M | 54.65%-825M | -405.52%-733M | 263.00%326M | -10.78%-226M |
Financing cash flow | -26.61%-5.7B | -114.73%-15.65B | -8.20%-5.36B | -114.82%-334M | -955.51%-5.46B | -10.43%-4.5B | 35.30%-7.29B | -163.73%-4.95B | 115.14%2.25B | -42.82%-517M |
Net cash flow | ||||||||||
Beginning cash position | 42.53%28.99B | 1.80%20.34B | 1.74%15.48B | -12.22%12.43B | 24.05%16.65B | 1.80%20.34B | -8.47%19.98B | 76.79%15.21B | -44.42%14.16B | -37.71%13.42B |
Current changes in cash | -245.09%-12.78B | 8,364.08%8.51B | 157.27%13.53B | 190.69%3.06B | -773.65%-4.37B | 47.56%-3.7B | 94.97%-103M | -53.47%5.26B | 106.24%1.05B | -83.47%649M |
Effect of exchange rate changes | 258.82%61M | 1.48%137M | 88.46%-15M | -200.00%-18M | 66.30%153M | -90.50%17M | -31.47%135M | -275.68%-130M | 0.00%-6M | 4,500.00%92M |
Cash adjustments other than cash changes | ---1M | -99.69%1M | --0 | 0.00%2M | ---- | ---- | --327M | ---1M | --2M | ---2M |
End cash Position | -2.31%16.27B | 42.53%28.99B | 42.53%28.99B | 1.74%15.48B | -12.22%12.43B | 24.05%16.65B | 1.80%20.34B | 1.80%20.34B | 76.79%15.21B | -44.42%14.16B |
Free cash flow | -1,508.09%-10.27B | 68.84%11.88B | -32.52%6.8B | 231.11%3.14B | -36.56%1.21B | 128.63%729M | -25.53%7.04B | 188.34%10.07B | -55.41%-2.4B | -55.31%1.91B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |